Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
Eflornithine cream favorably alters PFB
Washington - Results from a small exploratory translational research study suggest that eflornithine hydrochloride (HCl) 13.9 percent cream (Vaniqa) may be an effective treatment for pseudofolliculitis barbae, University of Minnesota researchers reported at the annual meeting of the Society for Investigative Dermatology.
Recent Videos
Related Content
